MoneyWorks4Me

Natural Capsules - Quaterly Results

13 Aug 2024 Evaluate
The total revenue for the quarter ended June 2024 remained nearly unchanged at Rs. 391.40 millions.Net Profit of the company move down -40.65% to Rs. 14.60  millions from Rs. 24.60 millions  in the same quarter last year.Operating profit for the quarter ended June 2024 decreased to 54.90 millions as compared to 66.40 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 391.40 377.00 3.82 391.40 377.00 3.82 1538.10 1728.70 -11.03
Other Income 7.60 5.80 31.03 7.60 5.80 31.03 31.40 10.60 196.23
PBIDT 54.90 66.40 -17.32 54.90 66.40 -17.32 239.10 365.00 -34.49
Interest 14.60 12.10 20.66 14.60 12.10 20.66 49.50 35.60 39.04
PBDT 40.30 54.30 -25.78 40.30 54.30 -25.78 189.60 329.40 -42.44
Depreciation 20.90 21.10 -0.95 20.90 21.10 -0.95 85.70 72.00 19.03
PBT 19.40 33.20 -41.57 19.40 33.20 -41.57 103.90 257.40 -59.63
TAX 4.80 8.60 -44.19 4.80 8.60 -44.19 25.90 65.40 -60.40
Deferred Tax 0.20 1.40 -85.71 0.20 1.40 -85.71 6.20 10.90 -43.12
PAT 14.60 24.60 -40.65 14.60 24.60 -40.65 78.00 192.00 -59.38
Equity 93.40 93.00 0.43 93.40 93.00 0.43 93.30 92.80 0.54
PBIDTM(%) 14.03 17.61 -20.36 14.03 17.61 -20.36 15.55 21.11 -26.38
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..